| NCT07209943 | Augmented Reality BCI Longitudinal Study for Persons With ALS, Stroke, TBI and SCI Utilizing Cognixion + Apple Vision Pro | Cognixion | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
| Recruiting soon | 10 | NA | Technology | General health | - System Usability Scale (SUS)
| 4 months | 16 October 2025 | 07 October 2025 | 1 | |
| NCT07207798 | Epidural Electrical Stimulation in Spinal Cord Injury (T11-L3) | Second Affiliated Hospital, School of Medicine, Zhejiang University | | - Age 16 - 65 yrs
- Level T11-L3
AIS B, C, D- 2 months - 2 years
- NOT have implanted cardiac pacemakers, cardioverters, or defibrillators
| Recruiting | 10 | NA | Technology | Standing/walking/mobility | - American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Ashworth and Modified Ashworth Scale (MAS)
- Functional Independence Measure (FIM)
- Pain Visual Analog Scale (VAS)
- Penn Spasm Frequency Scale (PSFS)
- Walking Index for Spinal Cord Injury (WISCI) and WISCI II
| 6 months | 01 July 2025 | 06 October 2025 | 1 | |
| NCT07204184 | Multisite Transspinal Stimulation for Augmenting Recovery in Spinal Cord Injury | City University of New York | | - Age 18 - 70 yrs
- Level C1-T9
AIS B, C, D- ≥ 6 months
- NOT have cochlear implants, pacemakers, implanted infusion device, and/or implanted stimulators of any type and purpose will be excluded to avoid their malfunction due to stimulation.
- NOT active skin pressure injury
| Recruiting | 36 | NA | Technology | General health | - 10 Meter Walking Test (10 MWT)
- 2 Minute Walk Test
- Ashworth and Modified Ashworth Scale (MAS)
| 4 weeks | 01 October 2025 | 02 October 2025 | 1 | |
| NCT07164846 | Effect of Neuro20 Functional Electrical Stimulation Suit on Autonomic Function, Muscle Performance, and Gait | Brooks Rehabilitation | | - Age ≥ 18 yrs
- Level C1-S5
AIS - All
- NOT have implanted medical devices, a pacemaker, or defibrillator
- NOT have an implanted stimulator or pump that cannot be turned off externally
| Recruiting | 30 | NA | Rehabilitation | Standing/walking/mobility | - 6-Minute Walk Test (6MWT)
- Blood Pressure and Heart Rate Regulation
| 4 weeks | 05 August 2025 | 10 September 2025 | 2 | |
| NCT07234903 | ARC-IM Therapy To Support and Promote Recovery of Ambulatory Functions in People With Subacute and Chronic Spinal Cord Injury | Ecole Polytechnique Fédérale de Lausanne | | - Age 18 - 65 yrs
- Level C1-T10
AIS A, B, C, D- All
- NOT have any active implanted devices
| Recruiting soon | 12 | NA | Technology | General health | - 10 Meter Walking Test (10 MWT)
- 6-Minute Walk Test (6MWT)
- Adverse Events (AEs)
- American Spinal Injury Association Impairment Scale (AIS): International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI)
- Berg Balance Scale (BBS)
- Goal Attainment Scaling (GAS) score
- Spinal Cord Injury Functional Ambulation Inventory (SCI-FAI)
- Timed Up and Go Test (TUG)
- Walking Index for Spinal Cord Injury (WISCI) and WISCI II
| 6 years | 01 January 2026 | 19 November 2025 | 2 | |
| NCT07227285 | Long-term Follow-up Study of Patients Who Received EG110A, a Non-replicative Herpes Simplex Virus 1-derived Gene Therapy | EG 427 | | - Age 18 - 75 yrs
- Level C1-L5
AIS A, B, C, D, E- ≥ 1 years
- have received at least one dose/injection of EG110A in Study EG110A-001-01 (NCT06596291: https://www.scitrialsfinder.net/trials/NCT06596291)
| Recruiting soon | 16 | PHASE1, PHASE2 | Drug | General health | | 5 years | 01 April 2026 | 12 November 2025 | 4 | |
